Media

Keep up to date with all the latest news and updates from Virax Biolabs.

 

Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID Patients

Virax Biolabs’ CEO James Foster Issues Letter to Shareholders

Dr. Nigel McCracken, Ph.D. – Chief Operating Officer, Virax Biolabs

16 Clinical Laboratory Predictions for 2024 (featuring James Foster)

“Regulatory reforms and incentives implemented by Middle Eastern countries have simplified market entry for life sciences companies” (featuring James Foster)

By Ayesha Siddiqui

Could a Predictive Test Fuel a Diagnostic Revolution? (featuring James Foster)

7 Reasons to Join ViraxImmune™’s T Cell Test Early Access Program

This week, we were excited to launch ViraxImmune™’s Research Use Only (RUO) Early Access Program. This program is designed to provide a new research tool and community for those committed

T Cell Secrets by James Foster

Virax Biolabs Group Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts Webinar

Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum

Understanding the Risks of RSV This Fall

As the leaves begin to change and temperatures start to drop, the approach of fall is met with anticipation and excitement. However, this year, a concerning shadow looms over the

The Importance of Fall Vaccinations Against Respiratory Illnesses

As the warm embrace of summer gradually gives way to the crisp coolness of fall, thoughts turn to pumpkin spice lattes, cozy sweaters, and the vibrant colors of changing leaves.